Breast-conserving surgeries in HER-positive breast cancer patients are performed too rarely in Poland

Kufel-Grabowska, Joanna; Radecka, Barbara; Streb, Joanna; Jagiełło-Gruszfeld, Agnieszka; Hudała-Klecha, Joanna; Szombara, Ewa; Sienkiewicz, Renata; Czartoryska-Arłukowicz, Bogumiła; Witasik, Piotr; Sokołowska, K; Wysocki, Wojciech M.

doi:10.5603/njo.2020.0047

Cited by 2 publications

(2 citation statements)

References 9 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These centers, organized in one location, provide highly qualified specialists and services that focus particularly on breast cancer detection and its treatment. Units consist of a multidisciplinary team involving geneticists, radiologists, pathologists, surgeons, oncologists, radiation oncologists and psychologists [29,30].…”

Section: Discussionmentioning

confidence: 99%

Retrospective analysis of the treatment of BRCA1 and BRCA2 mutation carriers – the experience of a single-center tertiary institution

Stępień,

Wow,

Kołacińska-Wow

2023

Nowotwory. Journal of Oncology

View full text Add to dashboard Cite

Introduction. Breast cancer gene 1 and 2 (BRCA1/2) mutation carriers are at a higher risk of developing breast cancer. There are several established risk-reducing therapies. Our study aimed to characterize the BRCA1/2 mutation carriers, and to evaluate the implemented treatment methods. Material and methods. A retrospective analysis of clinical records of 96 female patients hospitalized from October 2019 to December 2022 in the Breast Cancer Unit in Lodz, Poland. Results. Out of 85 BRCA1 and 11 BRCA2 mutation carriers, 96.88% received nipple-sparing or skin-sparing, unilateral or bilateral risk-reducing mastectomies. Out of all the patients, 36 developed 38 breast cancers. One patient was diagnosed with breast cancer 2 years after a bilateral risk-reducing mastectomy. The most common breast cancer subtype was triple-negative breast cancer (73.68%). The patients could receive surgery, chemotherapy, endocrine therapy and radiotherapy. 18 patients had neoadjuvant chemotherapy, in 6 of these patients a complete pathological response (ypT0N0) was achieved. Conclusions. Oncoplastic bilateral risk-reducing mastectomies are effective and safe procedures.

show abstract

Section: Discussionmentioning

confidence: 99%

Retrospective analysis of the treatment of BRCA1 and BRCA2 mutation carriers – the experience of a single-center tertiary institution

Stępień,

Wow,

Kołacińska-Wow

2023

Nowotwory. Journal of Oncology

View full text Add to dashboard Cite

show abstract

“…Treatment of breast cancer certainly has a negative impact on a patient's emotional state, their mental state, but also on the sexual satisfaction and intimate relations with a partner [34]. Patients treated with breast-conserving therapy are still relatively few in Poland [35]. Proper breast oncology surveillance during pregnancy, using safe and inexpensive methods including ultrasonography and biopsy of suspicious masses, can ensure the prevention of cancer development and progression [36].…”

Section: Discussionmentioning

confidence: 99%

Sexual well being of breast cancer patients

Lachowicz

Kufel-Grabowska

Bartoszkiewicz

et al. 2021

Nowotwory. Journal of Oncology

Self Cite

View full text Add to dashboard Cite

Introduction. Breast cancer is the most common cancer in women -both in Poland and around the world. In terms of the mortality rate, it subsides brest cancer with lung cancer. In 2018, almost 2 million new cases were reported worldwide, and almost 44 million women have been diagnosed with breast cancer in the last 5 years. Material. The aim of this paper is to present ways to improve the sexual well being of breast cancer patients. Methods. Analysis of the literature by oncologists, gynecologists, and psychologists was used for theoretical discussion. Results. Sexuality is an extremely important part of every woman's life, including those suffering from breast cancer. Surgery of the breast, a symbol of a woman's sexuality, and the negative effects of cancer therapy can alter a woman's perception of her own body and lower her libido. Sexual therapy which should be based on multi-faceted activities, is an extremely important part of breast cancer treatment. Conclusions. Therapeutic possibilities may be based on psychological and sexual therapies as well as pharmacological support (moisturizers, silicone lubricants, tampons inserted for several minutes with 4% vaginal lidocaine before intercourse, topical gels with estrogens, ospemifen, DHEA, testosterone).

show abstract

Breast-conserving surgeries in HER-positive breast cancer patients are performed too rarely in Poland

Cited by 2 publications

References 9 publications

Retrospective analysis of the treatment of BRCA1 and BRCA2 mutation carriers – the experience of a single-center tertiary institution

Retrospective analysis of the treatment of BRCA1 and BRCA2 mutation carriers – the experience of a single-center tertiary institution

Sexual well being of breast cancer patients

Contact Info

Product

Resources

About